• xmlui.mirage2.page-structure.header.title
    • français
    • English
  • Help
  • Login
  • Language 
    • Français
    • English
View Item 
  •   BIRD Home
  • LEDa (UMR CNRS 8007, UMR IRD 260)
  • LEDa : Publications
  • View Item
  •   BIRD Home
  • LEDa (UMR CNRS 8007, UMR IRD 260)
  • LEDa : Publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Browse

BIRDResearch centres & CollectionsBy Issue DateAuthorsTitlesTypeThis CollectionBy Issue DateAuthorsTitlesType

My Account

LoginRegister

Statistics

Most Popular ItemsStatistics by CountryMost Popular Authors
Thumbnail - Request a copy

Cost-effectiveness analysis of captopril treatment after myocardial infarction

Le Pen, Claude; Lévy, Emile; Bonte, J. (1994), Cost-effectiveness analysis of captopril treatment after myocardial infarction, Archives des maladies du coeur et des vaisseaux, 87, 6, p. 775-781

Type
Article accepté pour publication ou publié
Date
1994
Journal name
Archives des maladies du coeur et des vaisseaux
Volume
87
Number
6
Publisher
Société Française de Cardiologie
Pages
775-781
Metadata
Show full item record
Author(s)
Le Pen, Claude
Lévy, Emile
Bonte, J.
Abstract (EN)
The recently published "Survival and Ventricular Enlargement" (SAVE), prospective controlled trial over 4 years including over 2,000 patients, has shown that long-term treatment with captopril reduced cardiovascular mortality (- 19%) and morbidity in patients with post-infarction left ventricular dysfunction without signs of cardiac failure. Based on the trial data, the extra cost of treating the patients with captopril compared with the placebo branch is estimated at 9.3 million french francs. This expense is compensated by a reduction in the cost of hospitalisation for cardiac failure of 1.6 million francs and a reduction in the cost of further coronary events of 3.4 million francs. Above all, the extra cost is compensated by a gain of 47 deaths avoided, corresponding to about 493.5 years of life saved. The cost-effectiveness of captopril administration is therefore about 8.750 francs per year per life saved. The ratio is significantly less than that of other primary or secondary prevention therapeutic strategies. On this basis, we conclude that captopril therapy of high risk post-infarction patients is a solution that is not only medically effective but also economically sound.
Subjects / Keywords
Cost of Medical care; Medical economics; Cost-benefit analysis
JEL
I11 - Analysis of Health Care Markets

Related items

Showing items related by title and author.

  • Thumbnail
    Cost-effectiveness analysis of pembrolizumab versus standard-of-care chemotherapy for first-line treatment of PD-L1 positive (>50%) metastatic squamous and non-squamous non-small cell lung cancer in France 
    Chouaid, Christos; Bensimon, Lionel; Clay, Emilie; Millier, Aurélie; Levy-Bachelot, Laurie; Huang, Min; Lévy, Pierre (2019) Article accepté pour publication ou publié
  • Thumbnail
    The cost of treatment dropout in depression A cost-benefit analysis of fluoxetine vs. tricyclics 
    Le Pen, Claude; Lévy, Emile; Ravily, V.; Beuzen, J.N.; Meurgey, F. (1994) Article accepté pour publication ou publié
  • Thumbnail
    Treatment of peritonitis in France: Comparative cost-effectiveness of the association imipenem-cilastatin and other antibiotic therapy 
    Lévy, Emile; Lévy, Pierre (1993) Article accepté pour publication ou publié
  • Thumbnail
    The Economics of TRACE: A Cost-Effectiveness Analysis of Trandolapril in Postinfarction Patients with Left Ventricular Dysfunction 
    Fiessinger, Sylvie; Keller, Thomas; Lilliu, Hervé; Le Pen, Claude (1998) Article accepté pour publication ou publié
  • Thumbnail
    PMH35 – Cost-Effectiveness of Paliperidone Palmitate Versus other Antipsychotics for the Treatment of Schizophrenia in France 
    Doutriaux, Agathe; Cognet, Magali; Druais, Sylvain; Lançon, Christophe; Samalin, Ludovic; Lévy, Pierre; Godet, Annabelle; Guillon, Pascal (2014) Article accepté pour publication ou publié
Dauphine PSL Bibliothèque logo
Place du Maréchal de Lattre de Tassigny 75775 Paris Cedex 16
Phone: 01 44 05 40 94
Contact
Dauphine PSL logoEQUIS logoCreative Commons logo